Wednesday 24 October 2012

New Approach Improves The Safety Of Angioplasty In Patients With Coronary Bypass Graft Disease

Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone. Their findings were presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, at the Miami Beach Convention Center by Michael P... via Health News from Medical News Today Read More Here..

No comments:

Post a Comment